Pharmacologic profiling of corifollitropin alfa, the first developed sustained follicle stimulant.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  European Journal of Pharmacology

• Publication date

  2011-01-25

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejphar.2010.10.078PMID 21115001
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Corifollitropin alfa in a long GnRH agonist protocol: proof of concept trial.

  2010cited by this paper
• Absorption, Distribution, Metabolism and Excretion of Corifollitropin Alfa, a Recombinant Hormone with a Sustained Follicle-Stimulating Activity

  2010cited by this paper
• Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency.

  2009cited by this paper
• A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol

  2009cited by this paper
• Ongoing pregnancy rates with corifollitropin alfa/gonadotrophin-releasing hormone (GnRH) antagonist regimen are not impacted by endogenous luteinizing hormone (LH) levels

  2009cited by this paper
• The science behind 25 years of ovarian stimulation for in vitro fertilization.

  2006cited by this paper
• Effects of long-acting recombinant human follicle-stimulating hormone analogs containing N-linked glycosylation on murine folliculogenesis.

  2005cited by this paper
• Use of Follicle-Stimulating Hormone for the Treatment of Female Infertility – Current Concepts

  2005cited by this paper
• Emerging drugs in assisted reproduction

  2005cited by this paper
• Historical perspectives in gonadotrophin therapy.

  2004cited by this paper
• Long-acting follicle-stimulating hormone analogs containing N-linked glycosylation exhibited increased bioactivity compared with o-linked analogs in female rats.

  2004cited by this paper
• Glycosylation of an N-terminal extension prolongs the half-life and increases the in vivo activity of follicle stimulating hormone.

  2003cited by this paper
• Single dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females.

  2002cited by this paper
• Pharmacokinetics and pharmacodynamics of single-chain recombinant human follicle-stimulating hormone containing the human chorionic gonadotropin carboxyterminal peptide in the rhesus monkey.

  2002cited by this paper
• Human FSH isoforms: carbohydrate complexity as determinant of in-vitro bioactivity.

  2001cited by this paper
• Biological characterization of recombinant human follicle stimulating hormone isoforms.

  1999cited by this paper
• Structure-function relationship of recombinant follicle stimulating hormone (Puregon).

  1996cited by this paper
• Molecular biology and biochemistry of human recombinant follicle stimulating hormone (Puregon).

  1996influential reference
• Genetic engineering of human FSH (Gonal-F).

  1996cited by this paper
• Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and concentrations of gonadotropins and sex steroids in follicular fluid.

  1994cited by this paper
• Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit.

  1992influential reference
• Enhanced stimulation of follicle maturation and ovulatory potential by long acting follicle-stimulating hormone agonists with extended carboxyl-terminal peptides.

  1992influential reference
• Molecular structures of glycoprotein hormones and functions of their carbohydrate components.

  1992cited by this paper
• The biological role of the carboxyl-terminal extension of human chorionic gonadotropin [corrected] beta-subunit.

  1990cited by this paper
• The Biological Role of the Carboxyl-Terminal Extension of Human Chorionic Gonadotroin β-Subunit

  1990cited by this paper
• The glycoprotein hormones: recent studies of structure‐function relationships

  1988cited by this paper
• Glycoprotein hormones: structure and function.

  1981cited by this paper
• Assay of the follicle stimulating hormone based on the augmentation with human chorionic gonadotropin.

  1953influential reference

• A single dose of corifollitropin alfa is equipotent to a daily dose of 300 IU recombinant FSH regardless of ovarian reserve.

  2025cites this paper
• A novel long-acting recombinant follicle-stimulating hormone with hyperglycosylation exhibits improved pharmacokinetic and bioactivity on promoting follicle growth.

  2025cites this paper
• Development of a Long-Acting Follicle-Stimulating Hormone Using Serum Albumin Fab-Associated Technology for Female Infertility

  2024cites this paper
• Bioactivity and Pharmacodynamics of X002, a Follicle-stimulating Hormone-IgG4 Fc Fusion Protein.

  2023cites this paper
• Long-acting recombinant human follicle-stimulating hormone (SAFA-FSH) enhances spermatogenesis

  2023cites this paper
• Low responders may benefit from undergoing ovarian stimulation with a long GnRH agonist protocol with corifollitropin alfa followed by hMG

  2023cites this paper
• Mucin‐fused myeloid‐derived growth factor (MYDGF164) exhibits a prolonged serum half‐life and alleviates fibrosis in chronic kidney disease

  2022cites this paper
• FSH receptor genotype and its influence on the results of donor ovarian stimulation using corifollitropin alfa.

  2022cites this paper
• FSH for the Treatment of Male Infertility

  2020cites this paper
• The Conundrum of Poor Ovarian Response: From Diagnosis to Treatment

  2020cites this paper
• Corifollitropin alfa for poor responders patients, a prospective randomized study

  2020cites this paper
• Replacement of Male Mini-Puberty

  2019cites this paper
• Gene expression profiles of human granulosa cells treated with bioequivalent doses of corifollitropin alfa (CFA) or recombinant human follicle-stimulating hormone (recFSH)

  2019cites this paper
• Is corifollitropin alfa effective in controlled ovarian stimulation among all poor ovarian responders? A retrospective comparative study

  2019cites this paper
• El uso de la corifolitropina alfa en donantes de óvulos obtiene la misma eficiencia reproductiva y efectividad que la FSH recombinante, con una mayor comodidad para la donante

  2017cites this paper
• Preparation, characterization and application of long-acting FSH analogs for assisted reproduction.

  2017cites this paper
• Development and characterization of a novel long-acting recombinant follicle stimulating hormone agonist by fusing Fc to an FSH-β subunit.

  2016influential citation
• Effect of ovarian stimulation treatments on the embryo quality in rabbit Tesis

  2016cites this paper
• Efecto de la corifolitropina alfa en pacientes de fertilización in vitro-ICSI con falla previa en un protocolo de FSH/HMG: experiencia preliminar en México

  2016cites this paper
• Gonadotropin in Assisted Reproduction: An Evolution Perspective

  2015cites this paper
• Gonadotrophin replacement for induction of fertility in hypogonadal men.

  2015cites this paper
• Patient preference for a long-acting recombinant FSH product in ovarian hyperstimulation in IVF: a discrete choice experiment.

  2015cites this paper
• Efficacy and safety of late-start Corifollitropin-alfa administration for controlled ovarian hyperstimulation in IVF: a cohort, case–control study

  2015cites this paper
• Chapter 9 – Biobetter Biologics

  2015cites this paper
• Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech

  2014cites this paper
• Drugs Used for Controlled Ovarian Stimulation

  2014cites this paper
• Follicle-Stimulating Hormone

  2013cites this paper
• Prospective follow-up of 838 fetuses conceived after ovarian stimulation with corifollitropin alfa: comparative and overall neonatal outcome.

  2012cites this paper
• Corifollitropin alfa for female infertility

  2012cites this paper
• Is there a place for corifollitropin alfa in IVF/ICSI cycles? A systematic review and meta-analysis.

  2012cites this paper
• Corifollitropin Alfa

  2011cites this paper
• The role of corifollitropin alfa in controlled ovarian stimulation for IVF in combination with GnRH antagonist

  2011cites this paper
• Corifollitropin alfa: a new option to treat female infertility.

  2011cites this paper
• Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response.

  2011cites this paper
• To Market, To Market—2010

  2011cites this paper
• Corifollitropin alfa: a new recombinant FSH gonadotropin analog

  2011cites this paper
• Follicle-Stimulating Hormone

  1988cites this paper